(Q38734664)

6 September 2017

title

Tumor angiogenesis--characteristics of tumor endothelial cells (English)

1 reference

6 September 2017

0 references

1 reference

Kyoko Hida

1

1 reference

6 September 2017

Nako Maishi

series ordinal

2

1 reference

6 September 2017

Chisaho Torii

series ordinal

3

1 reference

6 September 2017

Yasuhiro Hida

series ordinal

4

1 reference

6 September 2017

publication date

15 February 2016

1 reference

International Journal of Clinical Oncology

6 September 2017

published in

1 reference

6 September 2017

volume

21

1 reference

6 September 2017

issue

2

1 reference

6 September 2017

page(s)

206-212

1 reference

Tumor angiogenesis: therapeutic implications

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Role of angiogenesis in tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Angiogenesis: an organizing principle for drug discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Inhibition of angiogenesis in the treatment of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Gastrointestinal perforation due to bevacizumab in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Apelin as a marker for monitoring the tumor vessel normalization window during antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Tumorigenesis and the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Molecular and cellular regulators of cancer angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Imaging of angiogenesis: from microscope to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Openings between defective endothelial cells explain tumor vessel leakiness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Basement membranes: structure, assembly and role in tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Cellular abnormalities of blood vessels as targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Steps toward mapping the human vasculature by phage display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

In vivo phage display and vascular heterogeneity: implications for targeted medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Tumor-associated endothelial cells with cytogenetic abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Genes expressed in human tumor endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Genes that distinguish physiological and pathological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Tumor endothelial markers: new targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Tumor vascular proteins as biomarkers in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Isolated tumor endothelial cells maintain specific character during long-term culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Neural-cell adhesion molecule (NCAM) expression by immature and tumor-derived endothelial cells favors cell organization into capillary-like structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Expression of Pax2 in human renal tumor-derived endothelial cells sustains apoptosis resistance and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Glioblastoma stem-like cells give rise to tumour endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Intracellular heterogeneity in adhesiveness of endothelium affects early steps in leukocyte adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Heterogeneity in endothelial responsiveness to cytokines, molecular causes, and pharmacological consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Heterogeneity in the rat brain vasculature revealed by quantitative confocal analysis of endothelial barrier antigen and P-glycoprotein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Calcification of multipotent prostate tumor endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

The proangiogenic phenotype of human tumor-derived endothelial cells depends on thrombospondin-1 downregulation via phosphatidylinositol 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Identification and characterization of a resident vascular stem/progenitor cell population in preexisting blood vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Identification of tumor endothelial cells with high aldehyde dehydrogenase activity and a highly angiogenic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Angiogenic factor signaling regulates centrosome duplication in endothelial cells of developing blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-016-0957-1

A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities

21 January 2018

1 reference

12 December 2020

Cell surface tumor endothelial markers are conserved in mice and humans

1 reference

12 December 2020

Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis

1 reference

12 December 2020

Significance of blood vessel leakiness in cancer.

1 reference

12 December 2020

Altered angiogenesis and survival in human tumor-derived endothelial cells.

1 reference

12 December 2020

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

1 reference

12 December 2020

Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironment

1 reference

12 December 2020

Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization.

1 reference

12 December 2020

Heterogeneity of tumor endothelial cells: comparison between tumor endothelial cells isolated from high- and low-metastatic tumors

1 reference

12 December 2020

10.1007/S10147-016-0957-1

Identifiers

DOI

1 reference

6 September 2017

1 reference